Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 116 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/17
End: 11/30/18
Due: 11/30/19
Phase: N/A
Priority: Normal
Start: 06/15/17
End: 06/15/19
Due: 06/15/20
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 12/01/16
End: 06/01/19
Due: 06/01/20
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 01/01/15
End: 01/01/21
Due: 01/01/22
Phase: N/A
Priority: Normal
Start: 10/15/15
End: 08/15/16
Due: 08/15/17
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 07/30/21
Due: 07/30/22
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 07/01/16
End: 07/01/19
Due: 07/01/20
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 08/01/16
End: 08/01/19
Due: 08/01/20
Phase: N/A
Priority: Normal
Start: 07/01/16
End: 07/01/19
Due: 07/01/20
Phase: N/A
Priority: Normal
Start: 07/01/16
End: 07/01/19
Due: 07/01/20
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 08/15/16
Due: 08/15/17
Phase: N/A
Priority: Normal
Start: 07/03/19
End: 06/30/20
Due: 06/30/21
Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 11/01/17
End: 08/30/19
Due: 08/30/20
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 06/30/20
Due: 06/30/21
Phase: N/A
Priority: Normal
Start: 04/01/16
End: 08/15/17
Due: 08/15/18
Phase: N/A
Priority: Normal
Start: 07/01/16
End: 07/01/19
Due: 07/01/20
Phase: N/A
Priority: Normal
Start: 01/01/15
End: 01/01/21
Due: 01/01/22
Phase: N/A
Priority: Normal
Start: 07/05/19
End: 06/15/20
Due: 06/15/21
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 12/31/14
Due: 12/31/15